{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:19:26Z","timestamp":1794849566378,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DK112946"],"award-info":[{"award-number":["DK112946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DK108842"],"award-info":[{"award-number":["DK108842"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["RR028009"],"award-info":[{"award-number":["RR028009"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DK098391"],"award-info":[{"award-number":["DK098391"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AG062334"],"award-info":[{"award-number":["AG062334"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bone loss is a frequent but not universal complication of hyperparathyroidism. Using antibiotic-treated or germ-free mice, we show that parathyroid hormone (PTH) only caused bone loss in mice whose microbiota was enriched by the Th17 cell-inducing taxa segmented filamentous bacteria (SFB). SFB\n                    <jats:sup>+<\/jats:sup>\n                    microbiota enabled PTH to expand intestinal TNF\n                    <jats:sup>+<\/jats:sup>\n                    T and Th17 cells and increase their S1P-receptor-1 mediated egress from the intestine and recruitment to the bone marrow (BM) that causes bone loss. CXCR3-mediated TNF\n                    <jats:sup>+<\/jats:sup>\n                    T cell homing to the BM upregulated the Th17 chemoattractant CCL20, which recruited Th17 cells to the BM. This study reveals mechanisms for microbiota-mediated gut\u2013bone crosstalk in mice models of hyperparathyroidism that may help predict its clinical course. Targeting the gut microbiota or T cell migration may represent therapeutic strategies for hyperparathyroidism.\n                  <\/jats:p>","DOI":"10.1038\/s41467-019-14148-4","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T06:03:06Z","timestamp":1579845786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells"],"prefix":"10.1038","volume":"11","author":[{"given":"Mingcan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Malik Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jau-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Neale","family":"Weitzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheinallt M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"key":"14148_CR1","doi-asserted-by":"crossref","unstructured":"Wein, M. N. & Kronenberg, H. M. Regulation of bone remodeling by parathyroid hormone. Cold Spring Harb Perspect Med. 8, a031237 (2018).","DOI":"10.1101\/cshperspect.a031237"},{"key":"14148_CR2","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","volume":"103","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian, J. P. Primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 103, 3993\u20134004 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"14148_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1677\/joe.1.06270","volume":"186","author":"A Iida-Klein","year":"2005","unstructured":"Iida-Klein, A. et al. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL\/J6 mice. J. Endocrinol. 186, 549\u2013557 (2005).","journal-title":"J. Endocrinol."},{"key":"14148_CR4","doi-asserted-by":"crossref","unstructured":"Potts, J. Primary hyperparathyroidism. in Metabolic Bone Diseases, 1 (Avioli, L. V. & Krane, S. eds.) 411\u2013442 (Academic Press, San Diego, 1998).","DOI":"10.1016\/B978-012068700-8\/50014-1"},{"key":"14148_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jbmr.5650040302","volume":"4","author":"SJ Silverberg","year":"1989","unstructured":"Silverberg, S. J. et al. Skeletal disease in primary hyperparathyroidism. J. Bone Min. Res 4, 283\u2013291 (1989).","journal-title":"J. Bone Min. Res"},{"key":"14148_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","volume":"22","author":"P Lips","year":"2001","unstructured":"Lips, P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22, 477\u2013501 (2001).","journal-title":"Endocr. Rev."},{"key":"14148_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1055\/a-0752-4533","volume":"50","author":"J Pierreux","year":"2018","unstructured":"Pierreux, J. & Bravenboer, B. Normocalcemic primary hyperparathyroidism: a comparison with the hypercalcemic form in a tertiary referral population. Horm. Metab. Res 50, 797\u2013802 (2018).","journal-title":"Horm. Metab. Res"},{"key":"14148_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11154-017-9421-4","volume":"18","author":"MR Portillo","year":"2017","unstructured":"Portillo, M. R. & Rodriguez-Ortiz, M. E. Secondary hyperparthyroidism: pathogenesis, diagnosis, preventive and therapeutic strategies. Rev. Endocr. Metab. Disord. 18, 79\u201395 (2017).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"14148_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000491041","volume":"51","author":"P Messa","year":"2019","unstructured":"Messa, P. & Alfieri, C. M. Secondary and tertiary hyperparathyroidism. Front Horm. Res 51, 91\u2013108 (2019).","journal-title":"Front Horm. Res"},{"key":"14148_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bone.2014.06.006","volume":"66C","author":"J Xiong","year":"2014","unstructured":"Xiong, J. et al. Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency. Bone 66C, 146\u2013154 (2014).","journal-title":"Bone"},{"key":"14148_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1172\/JCI11296","volume":"107","author":"LM Calvi","year":"2001","unstructured":"Calvi, L. M. et al. Activated parathyroid hormone\/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J. Clin. Invest 107, 277\u2013286 (2001).","journal-title":"J. Clin. Invest"},{"key":"14148_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1172\/JCI6629","volume":"104","author":"B Lanske","year":"1999","unstructured":"Lanske, B. et al. Ablation of the PTHrP gene or the PTH\/PTHrP receptor gene leads to distinct abnormalities in bone development. J. Clin. Invest 104, 399\u2013407 (1999).","journal-title":"J. Clin. Invest"},{"key":"14148_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1530\/JOE-10-0308","volume":"209","author":"WF Powell Jr.","year":"2011","unstructured":"Powell, W. F. Jr. et al. Targeted ablation of the PTH\/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J. Endocrinol. 209, 21\u201332 (2011).","journal-title":"J. Endocrinol."},{"key":"14148_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cmet.2009.07.010","volume":"10","author":"M Terauchi","year":"2009","unstructured":"Terauchi, M. et al. T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling. Cell Metab. 10, 229\u2013240 (2009).","journal-title":"Cell Metab."},{"key":"14148_CR15","first-page":"477","volume":"16","author":"T Uzawa","year":"1995","unstructured":"Uzawa, T., Hori, M., Ejiri, S. & Ozawa, H. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone. Bone 16, 477\u2013484 (1995).","journal-title":"Bone"},{"key":"14148_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cmet.2008.07.001","volume":"8","author":"Y Gao","year":"2008","unstructured":"Gao, Y. et al. T cells potentiate PTH-induced cortical bone loss through CD40L signaling. Cell Metab. 8, 132\u2013145 (2008).","journal-title":"Cell Metab."},{"key":"14148_CR17","doi-asserted-by":"publisher","first-page":"e12290","DOI":"10.1371\/journal.pone.0012290","volume":"5","author":"H Tawfeek","year":"2010","unstructured":"Tawfeek, H. et al. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. PLoS ONE 5, e12290 (2010).","journal-title":"PLoS ONE"},{"key":"14148_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cmet.2015.09.012","volume":"22","author":"JY Li","year":"2015","unstructured":"Li, J. Y. et al. IL-17A is increased in humans with primary hyperparathyroidism and mediates PTH-induced bone loss in mice. Cell Metab. 22, 799\u2013810 (2015).","journal-title":"Cell Metab."},{"key":"14148_CR19","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato, K. et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med 203, 2673\u20132682 (2006).","journal-title":"J. Exp. Med"},{"key":"14148_CR20","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec, P., Korn, T. & Kuchroo, V. K. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med 361, 888\u2013898 (2009).","journal-title":"N. Engl. J. Med"},{"key":"14148_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/imr.12035","volume":"252","author":"R Basu","year":"2013","unstructured":"Basu, R., Hatton, R. D. & Weaver, C. T. The Th17 family: flexibility follows function. Immunol. Rev. 252, 89\u2013103 (2013).","journal-title":"Immunol. Rev."},{"issue":"2","key":"14148_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jbmr.3600","volume":"34","author":"Jau-Yi Li","year":"2018","unstructured":"Li, J. Y., et al. IL-17 Receptor Signaling in Osteoblasts\/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production. J. Bone Miner. Res. 34, 349\u2013360 (2018).","journal-title":"Journal of Bone and Mineral Research"},{"key":"14148_CR23","doi-asserted-by":"crossref","unstructured":"Adamopoulos, I. E., et al. Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis. Res. Ther. 12, R29 (2010).","DOI":"10.1186\/ar2936"},{"key":"14148_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.intimp.2010.11.010","volume":"11","author":"K Okamoto","year":"2011","unstructured":"Okamoto, K. & Takayanagi, H. Osteoclasts in arthritis and Th17 cell development. Int. Immunopharmacol. 11, 543\u2013548 (2011).","journal-title":"Int. Immunopharmacol."},{"key":"14148_CR25","doi-asserted-by":"publisher","first-page":"330ra337","DOI":"10.1126\/scitranslmed.aad8996","volume":"8","author":"O Uluckan","year":"2016","unstructured":"Uluckan, O. et al. Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts. Sci. Transl. Med 8, 330ra337 (2016).","journal-title":"Sci. Transl. Med"},{"key":"14148_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13075-016-0998-x","volume":"18","author":"AT Shaw","year":"2016","unstructured":"Shaw, A. T., Maeda, Y. & Gravallese, E. M. IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis. Arthritis Res Ther. 18, 104 (2016).","journal-title":"Arthritis Res Ther."},{"key":"14148_CR27","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2016.10.020","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer, M. et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167, 1125\u20131136 (2016). e1128.","journal-title":"Cell"},{"key":"14148_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485\u2013498 (2009).","journal-title":"Cell"},{"key":"14148_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.chom.2008.09.009","volume":"4","author":"II Ivanov","year":"2008","unstructured":"Ivanov, I. I. et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337\u2013349 (2008).","journal-title":"Cell Host Microbe"},{"key":"14148_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2009.08.020","volume":"31","author":"V Gaboriau-Routhiau","year":"2009","unstructured":"Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677\u2013689 (2009).","journal-title":"Immunity"},{"key":"14148_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nature13279","volume":"510","author":"Y Yang","year":"2014","unstructured":"Yang, Y. et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 510, 152\u2013156 (2014).","journal-title":"Nature"},{"key":"14148_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.immuni.2014.03.005","volume":"40","author":"Y Goto","year":"2014","unstructured":"Goto, Y. et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 40, 594\u2013607 (2014).","journal-title":"Immunity"},{"key":"14148_CR33","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.chom.2017.10.007","volume":"22","author":"CP Bradley","year":"2017","unstructured":"Bradley, C. P. et al. Segmented filamentous bacteria provoke lung autoimmunity by inducing gut-lung axis Th17 cells expressing dual TCRs. Cell host microbe 22, 697\u2013704 (2017). e694.","journal-title":"Cell host microbe"},{"key":"14148_CR34","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.immuni.2016.10.020","volume":"45","author":"CF Krebs","year":"2016","unstructured":"Krebs, C. F. et al. Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney. Immunity 45, 1078\u20131092 (2016).","journal-title":"Immunity"},{"key":"14148_CR35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez, E. V. et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639\u2013646 (2007).","journal-title":"Nat. Immunol."},{"key":"14148_CR36","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.it.2015.10.005","volume":"36","author":"A Baeyens","year":"2015","unstructured":"Baeyens, A., Fang, V., Chen, C. & Schwab, S. R. Exit strategies: S1P signaling and T cell migration. Trends Immunol. 36, 778\u2013787 (2015).","journal-title":"Trends Immunol."},{"key":"14148_CR37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0041-1345(00)02126-6","volume":"33","author":"V Brinkmann","year":"2001","unstructured":"Brinkmann, V. et al. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression. Transpl. Proc. 33, 530\u2013531 (2001).","journal-title":"Transpl. Proc."},{"key":"14148_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"J Chun","year":"2010","unstructured":"Chun, J. & Hartung, H. P. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin. Neuropharmacol. 33, 91\u2013101 (2010).","journal-title":"Clin. Neuropharmacol."},{"key":"14148_CR39","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1681\/ASN.2009070741","volume":"21","author":"JE Turner","year":"2010","unstructured":"Turner, J. E. et al. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J. Am. Soc. Nephrol. 21, 974\u2013985 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"14148_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/path.2269","volume":"214","author":"FM Marelli-Berg","year":"2008","unstructured":"Marelli-Berg, F. M., Cannella, L., Dazzi, F. & Mirenda, V. The highway code of T cell trafficking. J. Pathol. 214, 179\u2013189 (2008).","journal-title":"J. Pathol."},{"key":"14148_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1196\/annals.1443.021","volume":"1143","author":"GJ Martinez","year":"2008","unstructured":"Martinez, G. J., Nurieva, R. I., Yang, X. O. & Dong, C. Regulation and function of proinflammatory TH17 cells. Ann. N. Y Acad. Sci. 1143, 188\u2013211 (2008).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"14148_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-12-394299-9.00002-3","volume":"115","author":"N Komatsu","year":"2012","unstructured":"Komatsu, N. & Takayanagi, H. Autoimmune arthritis: the interface between the immune system and joints. Adv. Immunol. 115, 45\u201371 (2012).","journal-title":"Adv. Immunol."},{"key":"14148_CR43","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/eji.201141938","volume":"41","author":"A Waisman","year":"2011","unstructured":"Waisman, A. T helper cell populations: as flexible as the skin? Eur. J. Immunol. 41, 2539\u20132543 (2011).","journal-title":"Eur. J. Immunol."},{"key":"14148_CR44","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","volume":"160","author":"DV Jovanovic","year":"1998","unstructured":"Jovanovic, D. V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 160, 3513\u20133521 (1998).","journal-title":"J. Immunol."},{"key":"14148_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03147-6","volume":"9","author":"M Tsukasaki","year":"2018","unstructured":"Tsukasaki, M. et al. Host defense against oral microbiota by bone-damaging T cells. Nat. Commun. 9, 701 (2018).","journal-title":"Nat. Commun."},{"key":"14148_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","volume":"441","author":"PR Mangan","year":"2006","unstructured":"Mangan, P. R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231\u2013234 (2006).","journal-title":"Nature"},{"key":"14148_CR47","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi, K. et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467, 967\u2013971 (2010).","journal-title":"Nature"},{"key":"14148_CR48","doi-asserted-by":"crossref","unstructured":"Zaiss, M. M., Jones, R. M., Schett, G. & Pacifici, R. The gut-bone axis: how bacterial metabolites bridge the distance. J. Clin. Invest. 129, 3018\u20133028 (2019).","DOI":"10.1172\/JCI128521"},{"key":"14148_CR49","doi-asserted-by":"publisher","first-page":"e89068","DOI":"10.1371\/journal.pone.0089068","volume":"9","author":"C Bondar","year":"2014","unstructured":"Bondar, C. et al. Role of Cxcr3\/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease. PLoS ONE 9, e89068 (2014).","journal-title":"PLoS ONE"},{"key":"14148_CR50","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","volume":"142","author":"YL Ma","year":"2001","unstructured":"Ma, Y. L. et al. Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142, 4047\u20134054 (2001).","journal-title":"Endocrinology"},{"key":"14148_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jim.2015.03.020","volume":"421","author":"AM Farkas","year":"2015","unstructured":"Farkas, A. M. et al. Induction of Th17 cells by segmented filamentous bacteria in the murine intestine. J. Immunol. Methods 421, 104\u2013111 (2015).","journal-title":"J. Immunol. Methods"},{"key":"14148_CR52","first-page":"239","volume":"39","author":"H Lang","year":"1989","unstructured":"Lang, H., Faller, H. & Schilling, S. [Coping with disease from the psychosomatic-psychotherapeutic viewpoint exemplified by pancreatectomized patients]. Psychother. Psychosom. Med. Psychol. 39, 239\u2013247 (1989).","journal-title":"Psychother. Psychosom. Med. Psychol."},{"key":"14148_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature14027","volume":"520","author":"P Schnupf","year":"2015","unstructured":"Schnupf, P. et al. Growth and host interaction of mouse segmented filamentous bacteria in vitro. Nature 520, 99\u2013103 (2015).","journal-title":"Nature"},{"key":"14148_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","volume":"118","author":"S Rakoff-Nahoum","year":"2004","unstructured":"Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229\u2013241 (2004).","journal-title":"Cell"},{"key":"14148_CR55","doi-asserted-by":"crossref","unstructured":"Lefrancois, L. & Lycke, N. Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer\u2019s patch, and lamina propria cells. Curr. Protoc. Immunol. Chapter 3, Unit 3 19 (2001).","DOI":"10.1002\/0471142735.im0319s17"},{"key":"14148_CR56","doi-asserted-by":"publisher","first-page":"E725","DOI":"10.1073\/pnas.1120735109","volume":"109","author":"B Bedi","year":"2012","unstructured":"Bedi, B. et al. Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH. Proc. Natl Acad. Sci. USA 109, E725\u2013E733 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"14148_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jbmr.2044","volume":"29","author":"JY Li","year":"2014","unstructured":"Li, J. Y. et al. The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b. J. Bone Min. Res. 29, 43\u201354 (2014).","journal-title":"J. Bone Min. Res."},{"key":"14148_CR58","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/jbmr.2394","volume":"30","author":"JW Robinson","year":"2015","unstructured":"Robinson, J. W. et al. T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatment. J. Bone Min. Res. 30, 695\u2013705 (2015).","journal-title":"J. Bone Min. Res."},{"key":"14148_CR59","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Min. Res. 25, 1468\u20131486 (2010).","journal-title":"J. Bone Min. Res."},{"key":"14148_CR60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Min. Res. 28, 2\u201317 (2013).","journal-title":"J. Bone Min. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14148-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14148-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14148-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T12:21:55Z","timestamp":1695644515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-14148-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14148"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-14148-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"468"}}